Are All Opioids Equivalent?
- In ICU
- Thu, 19 Mar 2026
Opioids are widely used in ICU care, but they are not interchangeable. Differences in pharmacology between agents such as fentanyl, morphine, and hydromorphone become clinically important in critically ill patients, particularly in the presence of organ dysfunction, prolonged infusions, and ventilator management. Research by Hannah Wunsch presented @ISICEM highlights that opioid selection is often shaped as much by local practice and clinician familiarity as by evidence.
Key factors in opioid choice include the clinical goal (analgesia, sedation, or respiratory suppression), desired duration of action, route of administration, and clinician familiarity with the drug. Safe and effective use depends on understanding each drug’s pharmacokinetics and titration.
Important pharmacological differences:
- Fentanyl has a rapid onset and short initial duration, but with prolonged infusion, its context-sensitive half-life increases, leading to accumulation, especially in hepatic dysfunction. It has no active metabolites, making it preferable in renal failure.
- Morphine is less lipophilic and produces active metabolites that accumulate in renal impairment, increasing the risk of prolonged sedation and neurotoxicity.
- Hydromorphone also has renally cleared metabolites, though typically less problematic than morphine’s.
- Remifentanil, metabolised by plasma esterases, may be advantageous in severe organ failure.
Organ dysfunction, particularly renal impairment, should strongly influence opioid choice. Morphine is generally avoided in renal failure, while fentanyl is often preferred. However, severe organ dysfunction can impair clearance of multiple opioids, necessitating careful selection and monitoring.
Opioids are an under-recognised contributor to delirium, with observational data suggesting a risk comparable to benzodiazepines. However, untreated pain also increases delirium risk, so clinicians must balance adequate analgesia with cautious dosing, frequent reassessment, and titration.
There is significant variability in opioid dosing across ICUs, much of which is driven by institutional culture rather than patient factors. Some units consistently use higher doses, indicating opportunities to reduce unnecessary exposure.
ICU opioid exposure is associated with only a modest increase in persistent opioid use after discharge, though higher cumulative doses may increase this risk slightly. Hydromorphone may carry a slightly higher risk of prolonged use compared with morphine or fentanyl, though evidence is limited.
Opioids can delay awakening and potentially affect readiness for extubation due to accumulation. While no strong evidence shows one opioid significantly prolongs ICU stay over another, all require careful down-titration during ventilator weaning.
Immediate pain control should remain the priority, but clinicians should use the lowest effective dose, reassess frequently, and consider non-opioid adjuncts where appropriate. Opioid-sparing strategies are valuable but must be balanced against the risks of polypharmacy.
While no single opioid has been definitively shown to produce superior short-term outcomes, the choice does matter. Clinicians should make deliberate, individualised decisions based on patient factors and drug properties rather than relying solely on habit or convention.
Source: ISICEM
Image Credit: iStock
